Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing
olism ofarachidonic acid that plays an essential role in metabolic inflammatory andcardiovascular physiology. The Company was founded by Dr. Bruce Hammock aProfessor at the University of California Davis who discovered s-EH. Formore information on Arete Therapeutics please visit http://www.aretetherapeutics.com .
Date:11/19/2008
olism of
arachidonic acid that plays an essential role in metabolic, inflammatory and
cardiovascular physiology. The Company was founded by Dr. Bruce Hammock, a
Professor at the
University of California, Davis, who discovered s-EH. For
more information on Arete Therapeutics, please visit
http://www.aretetherapeutics.com.
'/>"/>SOURCE Arete Therapeutics Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Arete Therapeutics Bolsters Management Team2.
Arete Therapeutics Names James Sabry, M.D., Ph.D., President and Chief Executive Officer3.
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors4.
TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments5.
Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting6.
Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference7.
Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference8.
TorreyPines Therapeutics Sells Alzheimers Disease Genetics Program to Eisai9.
Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association10.
MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 200811.
Cell Therapeutics Net Loss Declines as Operating Expenses Decrease By 58% in Third Quarter 2008